Loading…
Reported covered position: Legislative Counsel for former Sen. Kay Bailey Hutchison
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Planning Actively for Cancer Treatment (PACT) Act of 2015
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Comments submitted (with the Cancer Leadership Council) to the Senate Finance Committee on the Policy Options Document of the Bipartisan Chronic Care Working Group, specifically about improved care management for those with cancer. HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2017 · first_quarter · 1T
Congress: Patient Protection and Affordable Care Act (P.L. 111-148), ensuring coverage and access for cancer patients is preserved. NIH: 21st Century Cures Act, requesting timely transfer of funding to the National cancer Institutes. FDA: Reauthorization of the Prescription Drug User Fee Act (PDUFA) as well as new requirements for the FDA as outlined in the 21st Century Cures Act, request to incorporate psychosocial distress screening across the cancer care continuum HHS: CMS-9929-P, Patient Protection and Affordable Care Act; Market Stabilization, provisions related to open/special enrollment, guaranteed issue, actuarial value, and network adequacy.
Source: Senate LDA
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, survivorship, research and programs in FY 2017. H.R. 6, 21st Century Cures Act, provisions related to funding for cancer research and programs. National Cancer Moonshot Initiative, services and research for cancer survivors. CMS: Comment on notice of benefit and payment parameters for 2018, provisions related to standardized plans, network adequacy, prescription drug benefits, and risk adjustment payments. Congressional efforts to repeal and replace the Affordable Care Act.
Recognizing the importance of cancer research and the contributions of scientists, clinicians, cancer survivors and other patient advocates across the United States who are dedicated to finding a cure for cancer, and supporting the designation of May 2016 as "National Cancer Research Month".
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, survivoship, research and programs in FY 2017. National Cancer Moonshot Initiative, meetings and correspondence to discuss services and research for cancer survivors. Endorsement of H.Res. 717/S. Re. 459, supporting cancer research. Comment submitted to the FDA on the draft project proposal for the expanded access navigator for individual patient access. Comment submitted to the FDA in support of the creation of an Oncology Center of Excellence.
Medical Debt Relief Act of 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2017. FY 2016 omnibus spending package (P.L. 114-113), including $32 billion for medical research conducted and supported by the National Institutes of Health (NIH). National Cancer Moonshot Initiative, meeting to discuss services and research for cancer survivors. Endorsement of the Senate Medical Debt Relief Act (S.2592).
Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
H.Con.Res. 27/S.Con.Res.11 - Funding for cancer research and programs in FY 2016, and funding for the Labor, Health and Human Services budget. S. 318/HR 531, the Accelerating Biomedical Research Act - expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. The legislative agenda for 2015 and asking Congress to ensure that cancer remains a top priority. Comments submitted to NIH on draft NIH policy on Use of Single Use Institutional Review Board.
Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
H.Con.Res. 27/S.Con.Res.11 - Funding for cancer research and programs in FY 2016, and funding for the Labor, Health and Human Services budget. Asking Members of Congress to reject the proposed cuts to cancer prevention and early detection programs included in the Presidents FY 2016 budget.
Lymphedema Treatment Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 1608, the Lymphedema Treatment Act, requesting that physician prescribed lymphedema compression supplies would be covered under the Medicare program. HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program. [General feedback/No bill introduced] - Urging the Senate Committee on Finance to include establishment of a Medicare cancer care planning service among the reforms it recommends to improve chronic care. [Comment letter to HHS] - Requesting Medicare reimbursement of advance care planning (ACP) services in CY 2016.
Consolidated Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Planning Actively for Cancer Treatment (PACT) Act of 2015
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 1608, the Lymphedema Treatment Act, requesting that physician prescribed lymphedema compression supplies would be covered under the Medicare program. HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program. [General feedback/No bill introduced] - Urging the Senate Committee on Finance to include establishment of a Medicare cancer care planning service among the reforms it recommends to improve chronic care. [Comment letter to HHS] - Requesting Medicare reimbursement of advance care planning (ACP) services in CY 2016.
Planning Actively for Cancer Treatment (PACT) Act of 2015
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program. Comment letter to CMS on Request for Information Regarding Implementation of the Merit-Based Incentive Payment System, Promotion of Alternative Payment Models, and Incentive Payments for Participation in Eligible Alternative Payment Models.(CMS-3321-NC) Comment letter to CMS on the Proposed Notice of Benefit and Payment Parameters for 2017 (modifications to the standards for qualified health plans and the operations of health insurance exchanges).
Planning Actively for Cancer Treatment (PACT) Act of 2015
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program. Comment letter to CMS on proposed rule changes to Medicaid Managed Care, provisions related to quality cancer care (CMS-2390-P, Medicaid and Childrens Health Insurance Program (CHIP) Programs; Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability) Comment letter to CMS on proposed changes to Medicare physician fee schedule, provisions impacting care to cancer patients (CMS-1631-P, Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2016)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Accelerating Biomedical Research Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
H.Con.Res. 27/S.Con.Res.11 - Funding for cancer research and programs in FY 2016, and funding for the Labor, Health and Human Services budget. S. 318/HR 531, the Accelerating Biomedical Research Act - expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. The legislative agenda for 2015 and asking Congress to ensure that cancer remains a top priority. Comments submitted to NIH on draft NIH policy on Use of Single Use Institutional Review Board.
Accelerating Biomedical Research Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Accelerating Biomedical Research Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Accelerating Biomedical Research Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
H.Con.Res. 27/S.Con.Res.11 - Funding for cancer research and programs in FY 2016, and funding for the Labor, Health and Human Services budget. S. 318/HR 531, the Accelerating Biomedical Research Act - expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. The legislative agenda for 2015 and asking Congress to ensure that cancer remains a top priority. Comments submitted to NIH on draft NIH policy on Use of Single Use Institutional Review Board.
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Accelerating Biomedical Research Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Accelerating Biomedical Research Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
H.Con.Res. 27/S.Con.Res.11 - Funding for cancer research and programs in FY 2016, and funding for the Labor, Health and Human Services budget. S. 318/HR 531, the Accelerating Biomedical Research Act - expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. The legislative agenda for 2015 and asking Congress to ensure that cancer remains a top priority. Comments submitted to NIH on draft NIH policy on Use of Single Use Institutional Review Board.
Accelerating Biomedical Research Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
Accelerating Biomedical Research Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
H.Con.Res. 27/S.Con.Res.11 - Funding for cancer research and programs in FY 2016, and funding for the Labor, Health and Human Services budget. Asking Members of Congress to reject the proposed cuts to cancer prevention and early detection programs included in the Presidents FY 2016 budget.
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
H.Con.Res. 27/S.Con.Res.11 - Funding for cancer research and programs in FY 2016, and funding for the Labor, Health and Human Services budget. S. 318/HR 531, the Accelerating Biomedical Research Act - expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. The legislative agenda for 2015 and asking Congress to ensure that cancer remains a top priority. Comments submitted to NIH on draft NIH policy on Use of Single Use Institutional Review Board.
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S. 1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers.
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions related to co-morbidities and AIDS-related cancers.
America Gives More Act of 2014
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
H.R. 4719, American Gives More Act of 2014, provisions relating to charitable deductions.
Accelerating Biomedical Research Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Accelerating Biomedical Research Act (S.2658/H.R. 5580), increased funding for NIH. Letter to the Food and Drug Administration on patient participation in medical product demonstration. Letter to the Department of HHS on benefits and payment parameters for 2016 insurance plans.
Supporting America's Charities Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Supporting America's Charities Act (HR 5806), provisions related to deductions for charitable donations.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
S.1284/H.R.3547 Funding for cancer research and programs in FY 2015; Oncology payment models; CY 2015 Medicare Physician Fee Schedule proposed rule, with respect to funding granted to a certified continuing medical education (CME) provider.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
S.1284/H.R.3547 Funding for cancer research and programs in FY 2015
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
S.1284/H.R.3547 Funding for cancer research and programs in FY 2015; Oncology payment models.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
S.1284/H.R.3547 Funding for cancer research and programs in FY 2015; Healthcare systems and non-communicable disease funding globally; the Patient Protection and Affordable Care Act, provisions impacting access to care for cancer patients.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
S.1284/H.R. 3547 Funding for cancer research and programs in FY 2015
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
S.1284/H.R. 3547 Funding for cancer research and programs in FY 2015; Healthcare systems and non-communicable disease funding globally; the Patient Protection and Affordable Care Act, provisions impacting access to care for cancer patients.
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions related to co-morbidities and AIDS-related cancers.
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S. 1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers.
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Funding for cancer research and programs in the FY 2015 Labor, Health and Human Services appropriations bill; Legislation to repeal and replace the Sustainable Growth Rate (S.1871), provisions related to care planning for patients with chronic diseases; Comments on Medicare Advantage Part D proposed changes to medications with protected class; Oncology care reimbursement to providers.
Accelerating Biomedical Research Act
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Accelerating Biomedical Research Act (S.2658/H.R. 5580), increased funding for NIH. Letter to the Food and Drug Administration on patient participation in medical product demonstration. Letter to the Department of HHS on benefits and payment parameters for 2016 insurance plans.
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers.
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable diesease funding globally; (S.1545/H.R.3177) PEPFAR Stewardship and Oversight Act of 2013, provisions relating to co-morbidities and AIDS-related cancers.
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable diesease funding globally; (S.1545/H.R.3177) PEPFAR Stewardship and Oversight Act of 2013, provisions relating to co-morbidities and AIDS-related cancers.
PEPFAR Stewardship and Oversight Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: THE LIVESTRONG FOUNDATION · Firm: THE LIVESTRONG FOUNDATION
Impact of sequestration cuts and the FY 2013/14 budget on cancer research and patient care; Legislation to repeal and replace the Sustainable Growth Rate (S.1871), provisions related to care planning for patients with chronic diseases.
FY 2018 funding for cancer survivorship services President's Budget for FY 2018 and proposed cuts to NIH/NCI.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2016 · fourth_quarter · Q4
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, survivorship, research and programs in FY 2017. H.R. 6, 21st Century Cures Act, provisions related to funding for cancer research and programs. National Cancer Moonshot Initiative, services and research for cancer survivors. CMS: Comment on notice of benefit and payment parameters for 2018, provisions related to standardized plans, network adequacy, prescription drug benefits, and risk adjustment payments. Congressional efforts to repeal and replace the Affordable Care Act.
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, survivorship, research and programs in FY 2017.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2016 · third_quarter · Q3
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, survivorship, research and programs in FY 2017. National Cancer Moonshot Initiative, services and research for cancer survivors.
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, survivorship, research and programs in FY 2017.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2016 · second_quarter · Q2
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, survivorship, research and programs in FY 2017.
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, survivoship, research and programs in FY 2017. National Cancer Moonshot Initiative, meetings and correspondence to discuss services and research for cancer survivors. Endorsement of H.Res. 717/S. Re. 459, supporting cancer research. Comment submitted to the FDA on the draft project proposal for the expanded access navigator for individual patient access. Comment submitted to the FDA in support of the creation of an Oncology Center of Excellence.
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE, White House Office
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2016 · first_quarter · Q1
Comments submitted (with the Cancer Leadership Council) to the Senate Finance Committee on the Policy Options Document of the Bipartisan Chronic Care Working Group, specifically about improved care management for those with cancer. HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program.
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2017. FY 2016 omnibus spending package (P.L. 114-113), including $32 billion for medical research conducted and supported by the National Institutes of Health (NIH). National Cancer Moonshot Initiative, meeting to discuss services and research for cancer survivors. Endorsement of the Senate Medical Debt Relief Act (S.2592).
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2017. FY 2016 omnibus spending package (P.L. 114-113), including $32 billion for medical research conducted and supported by the National Institutes of Health (NIH).
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE, White House Office
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2015 · fourth_quarter · Q4
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2015 · third_quarter · Q3
HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program. Comment letter to CMS on proposed rule changes to Medicaid Managed Care, provisions related to quality cancer care (CMS-2390-P, Medicaid and Childrens Health Insurance Program (CHIP) Programs; Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability) Comment letter to CMS on proposed changes to Medicare physician fee schedule, provisions impacting care to cancer patients (CMS-1631-P, Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2016)
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2015 · second_quarter · Q2
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
HR 1608, the Lymphedema Treatment Act, requesting that physician prescribed lymphedema compression supplies would be covered under the Medicare program. HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program. [General feedback/No bill introduced] - Urging the Senate Committee on Finance to include establishment of a Medicare cancer care planning service among the reforms it recommends to improve chronic care. [Comment letter to HHS] - Requesting Medicare reimbursement of advance care planning (ACP) services in CY 2016.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2015 · first_quarter · Q1
H.Con.Res. 27/S.Con.Res.11 - Funding for cancer research and programs in FY 2016, and funding for the Labor, Health and Human Services budget. S. 318/HR 531, the Accelerating Biomedical Research Act - expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. The legislative agenda for 2015 and asking Congress to ensure that cancer remains a top priority. Comments submitted to NIH on draft NIH policy on Use of Single Use Institutional Review Board.
Healthcare systems and non-communicable disease funding globally. No specific bill number at that time.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2014 · fourth_quarter · Q4
Letter to the Centers for Medicare and Medicaid Services about oncology care models.
Supporting America's Charities Act (HR 5806), provisions related to deductions for charitable donations.
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions related to co-morbidities and AIDS-related cancers.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2014 · third_quarter · Q3
S.1284/H.R.3547 Funding for cancer research and programs in FY 2015; Oncology payment models; CY 2015 Medicare Physician Fee Schedule proposed rule, with respect to funding granted to a certified continuing medical education (CME) provider.
S.1284/H.R.3547 Funding for cancer research and programs in FY 2015
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2014 · second_quarter · Q2
S.1284/H.R.3547 Funding for cancer research and programs in FY 2015; Oncology payment models.
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers.
S.1284/H.R. 3547 Funding for cancer research and programs in FY 2015; Healthcare systems and non-communicable disease funding globally; the Patient Protection and Affordable Care Act, provisions impacting access to care for cancer patients.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2014 · first_quarter · Q1
Funding for cancer research and programs in the FY 2015 Labor, Health and Human Services appropriations bill; Healthcare systems and non-communicable disease funding globally; the Patient Protection and Affordable Care Act, provisions impacting access to care for cancer patients.
Funding for cancer research and programs in the FY 2015 Labor, Health and Human Services appropriations bill; Healthcare systems and non-communicable disease funding globally.
Funding for cancer research and programs in the FY 2015 Labor, Health and Human Services appropriations bill; Legislation to repeal and replace the Sustainable Growth Rate (S.1871), provisions related to care planning for patients with chronic diseases; Comments on Medicare Advantage Part D proposed changes to medications with protected class; Oncology care reimbursement to providers.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2013 · fourth_quarter · Q4
Healthcare systems and non-communicable disease funding globally; Impact of sequestration and the FY 2013/14 budget on cancer research and patient care.
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S.1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers.
Impact of sequestration cuts and the FY 2013/14 budget on cancer research and patient care; Legislation to repeal and replace the Sustainable Growth Rate (S.1871), provisions related to care planning for patients with chronic diseases.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2013 · third_quarter · Q3
Healthcare systems and non-communicable diesease funding globally; (S.1545/H.R.3177) PEPFAR Stewardship and Oversight Act of 2013, provisions relating to co-morbidities and AIDS-related cancers.
Healthcare systems and non-communicable diesease funding globally; Impact of sequestration cuts on cancer research and patient care
Impact of sequestration cuts on cancer research and patient care.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2013 · second_quarter · Q2
Healthcare systems and non-communicable disease funding
Healthcare systems and non-communicable disease funding; Impact of sequestration on cancer research and patient care.
Impact of sequestration on cancer research and patient care.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2013 · first_quarter · Q1
Heathcare systems and non-communicable disease funding; The impact of sequestration cuts on cancer research and patient care.
Heathcare systems and non-communicable disease funding; The impact of sequestration cuts on cancer research and patient care.
Healthcare systems and non-communicable disease funding.
THE LIVESTRONG FOUNDATION via THE LIVESTRONG FOUNDATION
2013 · first_quarter · RR
Health care reform; Tobacco control; Sequestration; Funding for cancer research, prevention and survivorship initiatives; Insurance coverage and reforms; Global health funding and programs for non-communicable diseases, including cancer.
Health care reform; Tobacco control; Sequestration; Funding for cancer research, prevention and survivorship initiatives; Insurance coverage and reforms; Global health funding and programs for non-communicable diseases, including cancer.
Health care reform; Tobacco control; Sequestration; Funding for cancer research, prevention and survivorship initiatives; Insurance coverage and reforms; Global health funding and programs for non-communicable diseases, including cancer.
HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program. Comment letter to CMS on Request for Information Regarding Implementation of the Merit-Based Incentive Payment System, Promotion of Alternative Payment Models, and Incentive Payments for Participation in Eligible Alternative Payment Models.(CMS-3321-NC) Comment letter to CMS on the Proposed Notice of Benefit and Payment Parameters for 2017 (modifications to the standards for qualified health plans and the operations of health insurance exchanges).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.Con.Res. 27/S.Con.Res.11 - Funding for cancer research and programs in FY 2016, and funding for the Labor, Health and Human Services budget. Asking Members of Congress to reject the proposed cuts to cancer prevention and early detection programs included in the Presidents FY 2016 budget.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 83: FY 2015 Omnibus; Consolidated and Further Continuing Appropriations Act - provisions related to NIH, NCI, and CDC funding for cancer programs/research.
Accelerating Biomedical Research Act (S.2658/H.R. 5580), increased funding for NIH. Letter to the Food and Drug Administration on patient participation in medical product demonstration. Letter to the Department of HHS on benefits and payment parameters for 2016 insurance plans.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S.1284/H.R.3547 Funding for cancer research and programs in FY 2015; Healthcare systems and non-communicable disease funding globally; the Patient Protection and Affordable Care Act, provisions impacting access to care for cancer patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R. 4719, American Gives More Act of 2014, provisions relating to charitable deductions.
S.1284/H.R. 3547 Funding for cancer research and programs in FY 2015
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
Healthcare systems and non-communicable disease funding globally; the PEPFAR Stewardship and Oversight Act of 2013 (S. 1545/H.R.3177), provisions relating to co-morbidities and AIDS-related cancers
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Healthcare systems and non-communicable disease funding globally; Impact of sequestration cuts and the FY 2013/14 budget on cancer research and patient care; and, the Patient Protection and Affordable Care Act, provisions impacting access to care for cancer patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Healthcare systems and non-communicable diesease funding globally; Impact of sequestration cuts on cancer research and patient care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
Healthcare systems and non-communicable disease funding; Impact of sequestration on cancer research and patient care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID)
Impact of sequestration cuts on cancer research and patient care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Health care reform; Tobacco control; Sequestration; Funding for cancer research, prevention and survivorship initiatives; Insurance coverage and reforms; Global health funding and programs for non-communicable diseases, including cancer.
Health care reform; Tobacco control; Sequestration; Funding for cancer research, prevention and survivorship initiatives; Insurance coverage and reforms; Global health funding and programs for non-communicable diseases, including cancer.
Health care reform; Tobacco control; Sequestration; Funding for cancer research, prevention and survivorship initiatives; Insurance coverage and reforms; Global health funding and programs for non-communicable diseases, including cancer.
Health care reform; Tobacco control; Sequestration; Funding for cancer research, prevention and survivorship initiatives; Insurance coverage and reforms; Global health funding and programs for non-communicable diseases, including cancer.